Drug Trial Radar · NCT07400588
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
58
Actual
Start
Dec 1, 2025
Primary completion
Sep 18, 2026
Study completion Sep 18, 2026
Sponsor
- Lead sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and tolerability of aleniglipron at doses up to 180 mg once daily (QD) in participants with T2DM who are living with obesity (body mass index \[BMI\] ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2).
Conditions
- Obese
- Obesity
- Obesity Type 2 Diabetes Mellitus
- Weight Loss
Interventions
AleniglipronDrug
Drug aleniglipron administered orally
PlaceboDrug
Drug placebo administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity and relationship of AEs/SAEsTime frame: Baseline to week 31
- Assessment of vital signsTime frame: Baseline to week 31
- Assessment of laboratory measuresTime frame: Baseline to week 31
- Assessment of Electrocardiograms (ECG)Time frame: Baseline to week 31
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Anniston, Alabama
Research Site
Lake Forest, California
Research Site
Lomita, California
Research Site
Hazelwood, Missouri
Research Site
Columbus, Ohio
Research Site
Moncks Corner, South Carolina
Research Site
Chattanooga, Tennessee
Research Site
Knoxville, Tennessee
Research Site
Austin, Texas
Research Site
DeSoto, Texas
Research Site
Houston, Texas
Research Site
Mesquite, Texas
Research Site
San Antonio, Texas
Research Site
San Antonio, Texas
Research Site
San Antonio, Texas
Research Site
Tomball, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.